Repligen
RGEN
#2039
Rank
ยฃ6.99 B
Marketcap
ยฃ124.34
Share price
-0.46%
Change (1 day)
5.93%
Change (1 year)
Categories

Repligen (RGEN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ0.63 Billion

According to Repligen 's latest financial reports the company's total liabilities are ยฃ0.63 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Repligen - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ0.68 B0.42%
2023-12-31ยฃ0.68 B32.5%
2022-12-31ยฃ0.51 B13.89%
2021-12-31ยฃ0.45 B64.35%
2020-12-31ยฃ0.27 B5.64%
2019-12-31ยฃ0.25 B107.14%
2018-12-31ยฃ0.12 B11.43%
2017-12-31ยฃ0.11 B15.48%
2016-12-31ยฃ97.37 M514.33%
2015-12-31ยฃ15.85 M49.01%
2014-12-31ยฃ10.63 M18.89%
2013-12-31ยฃ8.94 M12.23%
2012-12-31ยฃ7.97 M
2011-03-31ยฃ3.24 M-6.29%
2010-03-31ยฃ3.46 M8.21%
2009-03-31ยฃ3.2 M35.93%
2008-03-31ยฃ2.35 M30.71%
2007-03-31ยฃ1.8 M-1.61%
2006-03-31ยฃ1.83 M4.04%
2005-03-31ยฃ1.76 M33.38%
2004-03-31ยฃ1.32 M-7.24%
2003-03-31ยฃ1.42 M-23.95%
2002-03-31ยฃ1.87 M110.68%
2001-03-31ยฃ0.88 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novavax
NVAX
ยฃ1.00 B 59.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ1.16 B 85.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ0.94 B 50.14%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
ยฃ81.93 B 12,892.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
ยฃ38.90 B 6,069.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ58.72 B 9,213.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ86.74 B 13,655.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
ยฃ0.42 B-33.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
ยฃ61.81 M-90.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
ยฃ3.04 B 383.33%๐Ÿ‡บ๐Ÿ‡ธ USA